PHILADELPHIA--(BUSINESS WIRE)--AVAX Technologies, Inc. (OTCMarket: AVXT.OB) announced today that Dr. François Martelet has been appointed as a director on the Company’s Board of Directors (the “Board”), effective as of July 20, 2007.
Dr. Martelet is a senior pharmaceutical executive and brings to AVAX over 16 years of international experience. Most recently, he served as Vice-President and Global Franchise Head, Oncology with Merck & Co. Prior to that, Dr. Martelet was the Regional Pharmaceutical Head, Central & Eastern Europe, Middle East and Africa for Novartis Pharma AG, in addition served in various senior officer positions within units of Novartis Pharmaceuticals, including leading the Oncology Business Units in Asia, Latin America, Central and Eastern Europe, the Middle East and Africa.
